B
Bruce A. Posner
Researcher at University of Texas Southwestern Medical Center
Publications - 91
Citations - 4925
Bruce A. Posner is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 32, co-authored 82 publications receiving 4195 citations. Previous affiliations of Bruce A. Posner include University of Texas at Dallas & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
The structure of the G protein heterotrimer Giα1β1γ2
Mark A. Wall,David E. Coleman,Ethan Lee,Jorge A. Iñiguez-Lluhi,Bruce A. Posner,Alfred G. Gilman,Stephen R. Sprang +6 more
TL;DR: The structure of the G protein heterotrimer Gi alpha 1(GDP)beta 1 gamma 2 (at 2.3 A) reveals two nonoverlapping regions of contact between alpha and beta, an extended interface between beta and nearly all of gamma, and limited interaction of alpha with gamma as mentioned in this paper.
Journal ArticleDOI
Autosis is a Na + ,K + -ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia
Yang Liu,Sanae Shoji-Kawata,Rhea Sumpter,Yongjie Wei,Vanessa Ginet,Liying Zhang,Bruce A. Posner,Khoa D. Tran,Douglas R. Green,Ramnik J. Xavier,Stanley Y. Shaw,Peter G.H. Clarke,Julien Puyal,Beth Levine +13 more
TL;DR: A unique form of autophagy-dependent cell death is identified, a Food and Drug Administration-approved class of compounds that inhibit such death, and a crucial role for Na+,K+-ATPase in its regulation is identified.
Journal ArticleDOI
Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells.
Michael Ramirez,Michael Ramirez,Satwik Rajaram,Robert J. Steininger,Daria Osipchuk,Maike A. Roth,Leanna S. Morinishi,Louise Evans,Weiyue Ji,Chien Hsiang Hsu,Kevin Thurley,Shuguang Wei,Anwu Zhou,Prasad Koduru,Bruce A. Posner,Lani F. Wu,Lani F. Wu,Steven J. Altschuler,Steven J. Altschuler +18 more
TL;DR: The drug-tolerant persister state does not limit—and may even provide a latent reservoir of cells for—the emergence of heterogeneous drug-resistance mechanisms, including the most commonly observed clinical resistance mechanisms.
Journal ArticleDOI
Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration
Yongyou Zhang,Amar Desai,S. Yang,S. Yang,Ki Beom Bae,Ki Beom Bae,Monika I. Antczak,Stephen P. Fink,Shruti Tiwari,Joseph Willis,Noelle S. Williams,Dawn M. Dawson,David N. Wald,Wei Dong Chen,Zhenghe John Wang,Lakshmi Kasturi,Gretchen A. LaRusch,Lucy He,Fabio Cominelli,Luca Di Martino,Zora Djuric,Ginger L. Milne,Mark R. Chance,Juan Ramon Sanabria,Chris Dealwis,Debra Mikkola,Jacinth Naidoo,Shuguang Wei,Hsin Hsiung Tai,Stanton L. Gerson,Joseph M. Ready,Bruce A. Posner,James K V Willson,Sanford D. Markowitz +33 more
TL;DR: A compound that inhibits prostaglandin degradation enhances tissue regeneration in multiple organs in mice and promotes recovery of the hematopoietic system after bone marrow transplantation, prevents the development of ulcerative colitis in the intestine, and accelerates liver regeneration after hepatic surgery.
Journal ArticleDOI
Systematic Identification of Molecular Subtype-Selective Vulnerabilities in Non Small Cell Lung Cancer
Hyun Seok Kim,Saurabh Mendiratta,Jiyeon Kim,Chad V. Pecot,Jill E. Larsen,Iryna Zubovych,Bo Yeun Seo,Jimi Kim,Banu Eskiocak,Hannah Chung,Elizabeth A. McMillan,Sherry Y. Wu,Jef K. De Brabander,Kakajan Komurov,Jason E. Toombs,Shuguang Wei,Michael Peyton,Noelle S. Williams,Adi F. Gazdar,Bruce A. Posner,Rolf A. Brekken,Anil K. Sood,Ralph J. DeBerardinis,Michael G. Roth,John D. Minna,Michael A. White +25 more
TL;DR: Parallel screening of chemical and genetic perturbations within a panel of molecularly annotated NSCLC lines to identify intervention opportunities tightly linked to molecular response indicators predictive of target sensitivity identified three distinct target/response-indicator pairings that are represented with significant frequencies in the patient population.